Breaking News, Financial News, Promotions & Moves

Financial Report: ICON

Revenues up 5%, CFO named

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q Revenues: $243.0 million (+5%) 4Q Earnings: $4.1 million (-81%) FY Revenues: $946.0 million (+5%) FY Earnings: $31.5 million (-64%)   Comments: Business awards in the quarter were $308 million, a book-to-bill of 1.3. For the year, new business awards were $1.3 billion, a book-to-bill of 1.4. Also, Brendan Brennan has been appointed chief financial officer at ICON. Mr. Brennan has served as acting chief financial officer since October 2011. Previously he served as ICON’s senior vice...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters